Pyrimidines and CNS regulation

Trends in Pharmacological Sciences

Volumn 17, Issue 3, 1996, Pages 106-107

  Connolly, G P ^a   Simmonds, H A ^a   Duley, J A ^a   McLeod, H L ^a   Fernandez Salguero, P ^a   Gonzalez, F J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FLUORO BETA ALANINE; DIHYDROPYRIMIDINE DEHYDROGENASE; FLOXURIDINE; FLUOROACETIC ACID; FLUOROCITRIC ACID; FLUOROURACIL; PYRIMIDINE;

ATAXIA; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CEREBELLUM DISEASE; DRUG METABOLISM; ENZYME DEFICIENCY; GAIT DISORDER; GENETIC DISORDER; HUMAN; LETTER; LEUKOENCEPHALOPATHY; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRIMIDINE METABOLISM;

EID: 0029930340     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)20001-X     Document Type: Letter

References (9)

1. F.J. Gonzalez P. Fernandez-Salguero Trends Pharmacol. Sci. 16 1995 325 327
2. R.B. Diasio T.L. Beavers J.T. Carpenter J. Clin. Invest. 81 1988 47 51
3. G.P.J.M. Gerrits Nephron 58 1991 310 314
4. N.N. Karkishchenko Y.S. Makliakov B.V. Stradomsky Farmakol. Toksikol. 53 1990 67 72
5. R. Zang S-J. Soong T. Liu S. Barnes R.B. Diasio Drug Metah. Dispos. 20 1992 113 119
6. M. Kaneko Y. Kontani M. Kikugawa N. Tamaki Biochem. Biophys. Acta. 1122 1992 45 49
7. J. Berg-Johnsen M.S. Heier I.A. Langmoen Acta Neural. Scand. 75 1987 417 422
8. C.A. Roberts N.R. Kreisman M. Waltman Epilepsia 15 1974 479 500
9. G. Connolly Br. J. Pharmacol. 112 1994 357 359